Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy

被引：1
|
作者：
Fyfe I.
机构：
来源：
Nature Reviews Neurology | 2016年 / 12卷 / 7期
关键词：
D O I：
10.1038/nrneurol.2016.76
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：372 / 372
相关论文
共 50 条
  • [1] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [2] Modeling long-term "real world" outcomes of disease-modifying therapy in relapsing-remitting onset multiple sclerosis
    Skedgel, C.
    Brown, M. G.
    Bhan, V
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A377 - A377
  • [3] Real-world effectiveness of oral disease-modifying therapies for multiple sclerosis
    Thanh Phuong Pham Nguyen
    Thibault, Dylan
    Willis, Allison
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 124 - 125
  • [4] Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis
    Stuart, WH
    Cohan, S
    Richert, JR
    Achiron, A
    [J]. NEUROLOGY, 2004, 63 (11) : S19 - S27
  • [5] Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
    Graf, Jonas
    Ng, Huah Shin
    Zhu, Feng
    Zhao, Yinshan
    Wijnands, Jose M. A.
    Evans, Charity
    Fisk, John D.
    Marrie, Ruth Ann
    Tremlett, Helen
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis
    Krysko, Kristen M.
    Graves, Jennifer S.
    Rensel, Mary
    Weinstock-Guttman, Bianca
    Rutatangwa, Alice
    Aaen, Gregory
    Belman, Anita
    Benson, Leslie
    Chitnis, Tanuja
    Gorman, Mark
    Goyal, Manu S.
    Harris, Yolanda
    Krupp, Lauren
    Lotze, Timothy
    Mar, Soe
    Moodley, Manikum
    Ness, Jayne
    Rodriguez, Moses
    Rose, John
    Schreiner, Teri
    Tillema, Jan-Mendelt
    Mas, Michael Waltz
    MStat, T. Charles Casper
    Waubant, Emmanuelle
    [J]. ANNALS OF NEUROLOGY, 2020, 88 (01) : 42 - 55
  • [7] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
    C. McArthur
    C. Daruwalla
    M. Jayeskara
    J. W. L. Brown
    [J]. Journal of Neurology, 2023, 270 : 5127 - 5129
  • [8] Estimating long-term effects of disease-modifying drug, therapy in multiple sclerosis patients
    Rudick, RA
    Cutter, GR
    Baier, M
    Weinstock-Guttman, B
    Mass, MK
    Fisher, E
    Miller, DM
    Sandrock, AW
    [J]. MULTIPLE SCLEROSIS, 2005, 11 (06): : 626 - 634
  • [9] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
    Mcarthur, C.
    Daruwalla, C.
    Jayeskara, M.
    Brown, J. W. L.
    [J]. JOURNAL OF NEUROLOGY, 2023, 270 (10) : 5127 - 5129
  • [10] Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
    Jonas Graf
    Huah Shin Ng
    Feng Zhu
    Yinshan Zhao
    José M. A. Wijnands
    Charity Evans
    John D. Fisk
    Ruth Ann Marrie
    Helen Tremlett
    [J]. Scientific Reports, 13
12345